Search research articles
Contact Us
Filters
Showing results (161-170 of 171) with videos related to
Page
of 18
Sort By:
Cell
|
December 26, 2017
Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes
Marvin H Gee, Arnold Han, Shane M Lofgren, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 5, 2014
T-cell immunotherapy: looking forward
Jacqueline Corrigan-Curay, Hans-Peter Kiem, David Baltimore, et al.
Journal of Virology
|
June 5, 2015
Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection
Kevin O Saunders, Lingshu Wang, M Gordon Joyce, et al.
Science (New York, N.Y.)
|
June 28, 2003
Medicine. The need for a global HIV vaccine enterprise
Richard D Klausner, Anthony S Fauci, Lawrence Corey, et al.
Immunity
|
November 5, 2013
Anthracyclines induce DNA damage response-mediated protection against severe sepsis
Nuno Figueiredo, Angelo Chora, Helena Raquel, et al.
Nature Communications
|
April 15, 2026
Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer
Yapeng Su, Chunmei Liu, Xiang Lu, et al.
Nature Communications
|
July 2, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny
Theodore S Nowicki, Nataly Naser Al Deen, Cole W Peters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2014
Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma
Thinle Chodon, Begoña Comin-Anduix, Bartosz Chmielowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2018
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System
Cristina Puig-Saus, Giulia Parisi, Angel Garcia-Diaz, et al.
Nature Medicine
|
April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial
Joseph P Casazza, Evan M Cale, Sandeep Narpala, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 171) with videos related to
Sort By:
Page
of 18
Cell
|
December 26, 2017
Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes
Marvin H Gee, Arnold Han, Shane M Lofgren, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 5, 2014
T-cell immunotherapy: looking forward
Jacqueline Corrigan-Curay, Hans-Peter Kiem, David Baltimore, et al.
Journal of Virology
|
June 5, 2015
Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection
Kevin O Saunders, Lingshu Wang, M Gordon Joyce, et al.
Science (New York, N.Y.)
|
June 28, 2003
Medicine. The need for a global HIV vaccine enterprise
Richard D Klausner, Anthony S Fauci, Lawrence Corey, et al.
Immunity
|
November 5, 2013
Anthracyclines induce DNA damage response-mediated protection against severe sepsis
Nuno Figueiredo, Angelo Chora, Helena Raquel, et al.
Nature Communications
|
April 15, 2026
Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer
Yapeng Su, Chunmei Liu, Xiang Lu, et al.
Nature Communications
|
July 2, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny
Theodore S Nowicki, Nataly Naser Al Deen, Cole W Peters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2014
Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma
Thinle Chodon, Begoña Comin-Anduix, Bartosz Chmielowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2018
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System
Cristina Puig-Saus, Giulia Parisi, Angel Garcia-Diaz, et al.
Nature Medicine
|
April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial
Joseph P Casazza, Evan M Cale, Sandeep Narpala, et al.
Page
of 18